US HHS and GSK collaboration for $200 million
GlaxoSmithKline awarded up to $200 million by U.S. government to develop new antibiotics – GlaxoSmithKline (GSK) and the Biomedical Advanced Research and Development Authority (BARDA) have agreed to a first of its kind collaboration that will support the development of several antibiotics to fight antibiotic resistance and bioterrorism.